IL138339A0 - Mutant recombinant allergens - Google Patents

Mutant recombinant allergens

Info

Publication number
IL138339A0
IL138339A0 IL13833999A IL13833999A IL138339A0 IL 138339 A0 IL138339 A0 IL 138339A0 IL 13833999 A IL13833999 A IL 13833999A IL 13833999 A IL13833999 A IL 13833999A IL 138339 A0 IL138339 A0 IL 138339A0
Authority
IL
Israel
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
IL13833999A
Other languages
English (en)
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL138339(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of IL138339A0 publication Critical patent/IL138339A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13833999A 1998-03-16 1999-03-16 Mutant recombinant allergens IL138339A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16
PCT/DK1999/000136 WO1999047680A1 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens

Publications (1)

Publication Number Publication Date
IL138339A0 true IL138339A0 (en) 2001-10-31

Family

ID=8092687

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13833999A IL138339A0 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens
IL138339A IL138339A (en) 1998-03-16 2000-09-07 Non naturally occurring mutant recombinant allergens, methods for their preparation and pharmaceutical compositions comprising them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138339A IL138339A (en) 1998-03-16 2000-09-07 Non naturally occurring mutant recombinant allergens, methods for their preparation and pharmaceutical compositions comprising them

Country Status (19)

Country Link
US (1) US20040091500A1 (de)
EP (1) EP1062341B1 (de)
JP (1) JP2002506648A (de)
KR (1) KR20010041918A (de)
CN (1) CN1332029C (de)
AT (1) ATE408690T1 (de)
AU (1) AU749749B2 (de)
CA (1) CA2323687C (de)
DE (1) DE69939584D1 (de)
DK (1) DK1062341T3 (de)
ES (1) ES2313776T3 (de)
HU (1) HUP0101464A3 (de)
IL (2) IL138339A0 (de)
NO (1) NO328354B1 (de)
NZ (1) NZ506665A (de)
PL (1) PL194804B1 (de)
PT (1) PT1062341E (de)
WO (1) WO1999047680A1 (de)
ZA (1) ZA200004819B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001254622A1 (en) * 2000-04-28 2001-11-12 Novozymes A/S Laccase mutants
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
DK1340085T3 (da) * 2000-10-17 2008-12-01 Besst Test Aps Assay til direkte detektion af en biologisk celle i en legemsvæskepröve
ES2317955T3 (es) * 2000-11-16 2009-05-01 Alk-Abello A/S Alergenos mutantes.
ATE347376T1 (de) * 2000-12-28 2006-12-15 Biomay Prod & Handel Behandlung von allergien
JP2005508134A (ja) * 2001-03-02 2005-03-31 ザ ロックフェラー ユニヴァーシティ 天然アレルゲンの免疫原性を保持する、アレルゲン性が低下した組み換えハイブリッドアレルゲン構築体
WO2003031981A2 (en) * 2001-10-05 2003-04-17 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
WO2003072601A1 (de) * 2002-02-27 2003-09-04 Merck Patent Gmbh VERFAHREN ZUR HERSTELLUNG VON HYPOALLERGENEM BIRKENPOLLENHAUPTALLERGEN rBet v 1
AU2003223934A1 (en) * 2002-05-16 2003-12-02 Alk Abello A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
JP2006520184A (ja) * 2002-11-01 2006-09-07 アルカベロ アクチェセルスカプ 組換えタンパク質変種
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
AU2004216559B2 (en) 2003-02-28 2010-05-27 Alk-Abello A/S Dosage form having a saccharide matrix
RU2006126051A (ru) 2003-12-19 2008-01-27 Альк-Абелло А/С (Dk) Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта
EP1933867A1 (de) 2005-10-04 2008-06-25 Alk-Abello A/S Feste impfstoff-formulierung
ITMI20052517A1 (it) * 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
WO2007123488A1 (en) * 2006-04-20 2007-11-01 National University Of Singapore Recombinant lactobacillus and use of the same
US20080199485A1 (en) * 2007-02-15 2008-08-21 Mannkind Corporation Method for enhancing T cell response
WO2008116936A1 (en) 2007-03-28 2008-10-02 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (de) 2007-08-21 2009-02-25 Biomay AG Hypoallergene Moleküle
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
EP2442828B1 (de) 2009-06-19 2016-08-03 Alk-Abelló S.A. Neuartige weise zur verabreichung von allergen bei einer allergenspezifischen immuntherapie
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (de) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen zur vorbeugenden Behandlung von Allergien
JP2023502943A (ja) * 2019-11-13 2023-01-26 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン エアロアレルゲン関連アレルギーと炎症とを治療するナノエマルジョン組成物
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
IL138339A (en) 2009-06-15
NO328354B1 (no) 2010-02-01
PL343029A1 (en) 2001-07-30
HUP0101464A3 (en) 2004-10-28
PT1062341E (pt) 2008-12-24
EP1062341A1 (de) 2000-12-27
HUP0101464A2 (hu) 2001-08-28
ATE408690T1 (de) 2008-10-15
NO20004614D0 (no) 2000-09-15
AU2714799A (en) 1999-10-11
HK1033591A1 (en) 2001-09-07
DE69939584D1 (de) 2008-10-30
EP1062341B1 (de) 2008-09-17
NO20004614L (no) 2000-10-26
CN1332029C (zh) 2007-08-15
ES2313776T3 (es) 2009-03-01
AU749749B2 (en) 2002-07-04
WO1999047680A1 (en) 1999-09-23
CN1293710A (zh) 2001-05-02
KR20010041918A (ko) 2001-05-25
CA2323687C (en) 2008-11-25
CA2323687A1 (en) 1999-09-23
PL194804B1 (pl) 2007-07-31
NZ506665A (en) 2003-08-29
DK1062341T3 (da) 2008-11-03
US20040091500A1 (en) 2004-05-13
ZA200004819B (en) 2001-05-30
JP2002506648A (ja) 2002-03-05

Similar Documents

Publication Publication Date Title
ZA200004819B (en) Mutant recombinant allergens.
AU2350502A (en) Novel mutant allergens
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2003020889A3 (en) Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
AP2001002187A0 (en) Piperidines as CCR5 modulators.
EP1992643A3 (de) Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Tumoren
AU3227700A (en) Skin sanitizing compositions
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
BG102818A (en) D-manitol and method for its preparation
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
MX9708426A (es) Polipeptido hk2 de variante estable.
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002046211A3 (en) Peptides derived from colostrinin
BG101787A (en) Aprotinine options having improved properties
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
WO2001083722A3 (en) Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
AU8349301A (en) Dna vaccines encoding hiv accessory proteins
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
GB2374871A (en) Peptide fragments of colostrinin and their use
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins